Related Posts
Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. on $4.1 Million Public Offering
Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. on NASDAQ Uplisting and $9.4 Million Public Offering
Partner Harvey Kesner Represents MusclePharm Corporation in $6M Financing
Partner Harvey Kesner Represents ChromaDex on $2M Registered Direct Offering of Common Stock and Warrants
